BioWorld

Nov. 15, 2005

View Archived Issues

Viventia Merging, Becoming Private: C$12M To Pay Debt

Read More

PDUFA Being Reviewed Prior To Reauthorization

Read More

Speedel Presents Confirmatory Positive SPP301 Phase II Data

Read More

Other News To Note

Read More

OSI, Eyetech Close Merger After Look At Lucentis Data

Although it had to work on the weekend to calm any fears, OSI Pharmaceuticals Inc. closed its merger with Eyetech Pharmaceuticals Inc. Monday - much to the chagrin of some OSI analysts and investors. (BioWorld Today) Read More